10:00 AM EST - Amorfix Life Sciences. : announced its operational and financial results for the year ended March 31, 2012. For the year ended March 31, 2012 the Company reported a net loss from operations of $2,543,813 ($0.05 per share) compared to a net loss of $3,200,287 ($0.07 per share) for the year ended March 31, 2011. For the year ended March 31, 2012 revenue for services and sales was $90,882 as compared to $119,900 in the comparative period. Amorfix Life Sciences.
shares T.AMF are trading up $0.03 at $0.46.
